Anurag Kuhad

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (154)

• Chewable Gels
  Biotechnological Innovation and Sustainable Developmental Goals Fostering Good Health and Wellbeing 2025 DOI: 10.1201/9781032660592-28
  +Save
• Development & validation of a simple, sensitive, robust, reproducible & economical spectrofluorimetric method for estimation of taurine in novel chewable gel
  IBRO NEUROSCIENCE REPORTS 2025 DOI: 10.1016/J.IBNEUR.2024.11.010
  +Save
• Allyl isothiocyanate, a TRPA1 agonist, protects against olanzapine-induced hypothalamic and hepatic metabolic aberrations in female mice
  BIOCHEMICAL PHARMACOLOGY 2024 DOI: 10.1016/J.BCP.2024.116074
  +Save
• Exploring Astrocytes Involvement and Glutamate Induced Neuroinflammation in Chlorpyrifos-Induced Paradigm Of Autism Spectrum Disorders (ASD)
  NEUROCHEMICAL RESEARCH 2024 DOI: 10.1007/S11064-024-04191-Z
  +Save
• Herbal Drugs for Management of Migraine Pain
  Management of Migraine Pain Emerging Opportunities and Challenges 2024 DOI: 10.1007/978-981-97-4529-6_8
  +Save
• Protective effect of olopatadine hydrochloride against LPS-induced acute lung injury: via targeting NF-κB signaling pathway
  INFLAMMOPHARMACOLOGY 2024 DOI: 10.1007/S10787-023-01353-3
  +Save
• Protective effects of menthol against olanzapine-induced metabolic alterations in female mice
  EUROPEAN JOURNAL OF PHARMACOLOGY 2024 DOI: 10.1016/J.EJPHAR.2024.177010
  +Save
• Repurposing Niclosamide as a plausible neurotherapeutic in autism spectrum disorders, targeting mitochondrial dysfunction: a strong hypothesis
  METABOLIC BRAIN DISEASE 2024 DOI: 10.1007/S11011-023-01247-X
  +Save
• Repurposing of niclosamide, an anthelmintic, by targeting ERK/MAPK signaling pathway in the experimental paradigm of autism spectrum disorders
  EUROPEAN JOURNAL OF PHARMACOLOGY 2024 DOI: 10.1016/J.EJPHAR.2024.176902
  +Save
• The Neurobiology of Migraine and Overview of Migraine Management
  Management of Migraine Pain Emerging Opportunities and Challenges 2024 DOI: 10.1007/978-981-97-4529-6_2
  +Save